Case Study:
Using Large Language Models (LLMs) like ChatGPT to Speed Up Medical Literature Monitoring and Insights
How Large Language Models are helping medical affairs teams increase productivity and reduce medical literature monitoring time
The Client
The client was spending significant time keeping up to date with monitoring and evaluating new medical content. This was a very resource-intense activity and they wanted a way to automate part of this.
The Solution
Using data-driven Natural Language Intelligence (including LLMs) to combine scale and flexibility with contextual understanding, and precision to provide content intelligence for deeper understanding and efficiency.
The Outcome
- Significant Increase in productivity (average from client estimate following implementation is 1000%)
- Significant decrease in literature monitoring time (average from client estimate following implementation is 82-92%)
- Vastly improved tracking to support portfolio products
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.
What the EU AI Act Postponement Actually Means for Pharma AI Governance Globally
The timeline moved. The governance burden did not. On 7 May 2026, the European Parliament and the Council reached a provisional political agreement on the
The Copilot Delusion: Why “We Only Use Copilot” Is Not an AI Governance Strategy
Choosing one tool and writing a policy around it feels like control. Under the regulations now shaping pharma AI, it answers the wrong question entirely.
From Use Case to Working AI Agent Inside Your Pharma Environment
There is a specific pattern emerging across the pharmaceutical industry. Functional leaders in regulatory affairs, medical affairs, commercial, and market access have now seen enough